{
    "Trade/Device Name(s)": [
        "Rightest Blood Glucose Monitoring System"
    ],
    "Submitter Information": "Bionime Corporation",
    "510(k) Number": "K062567",
    "Predicate Device Reference 510(k) Number(s)": [
        "K042678",
        "K053635"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA"
    ],
    "Summary Letter Date": "February 2, 2007",
    "Summary Letter Received Date": "February 5, 2007",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Rightest Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Amperometry"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Monitoring System",
        "Meter",
        "Test Strips",
        "Control Solution",
        "Lancing Device",
        "Lancets",
        "Code Key",
        "Check key"
    ],
    "Document Summary": "FDA 510(k) summary for Rightest Blood Glucose Monitoring System for quantitative measurement of glucose in capillary whole blood from fingertip, palm, and forearm for diabetes management",
    "Indications for Use Summary": "Intended for in vitro diagnostic use by professional healthcare personnel or people with diabetes at home to measure glucose concentration in capillary whole blood from fingertip, palm, and forearm to aid diabetes management; not intended for neonate blood samples",
    "fda_folder": "Clinical Chemistry"
}